News und Analysen
Freshpet Stock: Leading the Pack with Solid Earnings Results
Freshpet (NASDAQ: FRPT) is a well-known refrigerated pet food products company. Freshpet’s earnings for Q4 2023 and FY 2023 have caught market attention, sending the stock up over 15% . This surge
Insider selling at JPM: A Closer Look Amidst Historic CEO Sale
The recent insider selling activity at JPMorgan Chase & Co. (NYSE: JPM), a leading banking and financial institution, has drawn notable attention, with CEO Jamie Dimon making his first-ever stock
Insider selling at JPM: A Closer Look Amidst Historic CEO Sale
The recent insider selling activity at JPMorgan Chase & Co. (NYSE: JPM), a leading banking and financial institution, has drawn notable attention, with CEO Jamie Dimon making his first-ever stock
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Workday, Inc. (NASDAQ: WDAY) issued a lackluster FQ2 report that left the market wishing for more. However, as tepid as the results are, underperformance is relative to analysts' consensus
Palantir Stock Has It all… Except the Analysts' Support
Palantir Technologies (NYSE: PLTR) stock is gaining traction and may advance another 50% or more in the next few months. The company has a solid product, growing demand, deepening penetration and
Palantir Stock Has It all… Except the Analysts' Support
Palantir Technologies (NYSE: PLTR) stock is gaining traction and may advance another 50% or more in the next few months. The company has a solid product, growing demand, deepening penetration and
Palantir Stock Has It all… Except the Analysts' Support
Palantir Technologies (NYSE: PLTR) stock is gaining traction and may advance another 50% or more in the next few months. The company has a solid product, growing demand, deepening penetration and
3 wealth-compounding stocks to beat the market this decade
Because the Federal Reserve (the Fed) has announced potential interest rate cuts for this year, an expectation priced in for March is now being pushed as far back as May or June, according to the
Eilt: Sensationelle Krypto-Übernahme - Massives Kaufsignal. Diese Krypto-Aktie jetzt kaufen. Neuer 421% Crypto Hot Stock nach 5.544% mit Ethereum ($ETH) und 1.337.328% mit Bitcoin ($BTC)
Eilt: Sensationelle Krypto-Übernahme - Massives Kaufsignal. 421% Crypto Hot Stock nach 1.337.328% mit Bitcoin ($BTC)
28.02.24 08:18
Vancouver (www.aktiencheck.de, Anzeige)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk
28.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk
28.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk
28.02.24 08:03
London (www.aktiencheck.de, Anzeige)
Autozone stock price is still in the rally zone
Autozone (NYSE: AZO) shares surged following the FQ2 report, confirming the uptrend is intact. Because the news aligns with the outlook for growth and capital returns, the trend will likely
Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties
Vancouver, British Columbia, February 27, 2024 – Westward Gold Inc. (CSE: WG, OTCQB: WGLIF, FSE: IM50) (“Westward” or the “Company”) is pleased to provide preliminary details surrounding
New highs are coming for Lowe’s stock despite mixed results
At face value, Lowe’s Companies (NYSE: LOW) had a rough Q4 compared to competitor Home Depot, but the details within the report belie that assessment. Comps were weak, but the company is building
3 lithium stocks to ride a multi-year cycle
The world used to run on coal and other types of fuel that powered the different titans of industry. This cycle started with transportation through railways to factories and steel mills that were
Domino's Q4 2023 report: Hot and fresh or cold and crusty?
Domino's Pizza Inc. (NYSE: DPZ) is a globally recognized pizza delivery brand recently gaining noteworthy attention. Domino's financial results for the fourth quarter of 2023 were reported, and
Goldman upgraded Nvidia stock, one metric says it could go higher
Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)
Goldman upgraded Nvidia stock, one metric says it could go higher
Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)
Goldman upgraded Nvidia stock, one metric says it could go higher
Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)
Quad/Graphics is a benefactor of the advertising rebound
Quad/Graphics Inc. (NYSE: QUAD) is a global full-service marketing solutions firm for commercial clients in the retail, healthcare, financial services, publishing and consumer packaging
bluebird bio: How to play LEAPS options for growth and income
Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG
bluebird bio: How to play LEAPS options for growth and income
Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG
bluebird bio: How to play LEAPS options for growth and income
Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG
Thinking long-term? Don't lose interest in Pinterest
Pinterest Inc. (NYSE: PINS) stock suffered a 12% sell-off on its Q4 2023 earnings report. The main reason for the selling was a miss on the top line, as revenues failed to beat consensus analyst